Please assess the completion status of the following clinical trial:

Trial Title: Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female over 18 yrs.~* Female subjects of childbearing potential must have negative pregnancy test and provide contraception.~* Subjects must have confirmed diagnosis of primary open-angle glaucoma or ocular hypertension in both eyes.~* Subjects who are or have been insufficiently responsive to IOP reducing monotherapy and use of either study medication is deemed appropriate.~* Subjects able to complete questionnaires and provide informed consent.~Exclusion Criteria:~* Female subjects who are pregnant, planning to become pregnant during study period, breast feeding or not practicing a reliable method of birth control.~* Subjects wherein the study drugs are containdicated.~* Subjects who have had introcular surgery with 6 months (3 months for laser).~* Subjects with known side effects/ allergy or sensitivity to any component of study treatments.~* Subjects with any uncontrolled systemic disease.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): brimonidine/timolol. Fixed-combination monotherapy.
- 2 (Type: ACTIVE_COMPARATOR): dorzolamide/timolol. Fixed-combination monotherapy.
- 3 (Type: ACTIVE_COMPARATOR): prostaglandin analogue+ brimonidine/timolol fixed combination.
- 4 (Type: ACTIVE_COMPARATOR): prostaglandin analogue+dorzolamide/timolol fixed combination.

Based on this trial design, predict the completion outcome and termination type (if applicable).